🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.
Salud Compra fuertePrecio actual
59,53 USD
Máx. histórico
2.925,00
12010 días
Split 1:10 del 17/11/2011
Caída desde máximo
-97,96%
Rango 52 semanas
37,06 – 95,49
Variación hoy
-0,07%
Cierre anterior
59,57
Rango de hoy
59,25 – 60,89
Volumen hoy
1.327.132
Peor caída histórica
-99,96%
16/12/1993 → 16/12/2016
Aún sin recuperar
Volatilidad anualizada ⓘ
231,88%
- Nombre completo
- Arrowhead Pharmaceuticals, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 711
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 107,71 USD (puede no estar actualizado)
- Primera cotización
- 16/12/1993
- Precio actualizado
- hace 6 horas
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
| Fecha | Ratio |
|---|---|
| 17/11/2011 | 1:10 |
| 15/01/2004 | 1:65 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/01/2026 | 66,30 | 68,25 | 65,00 | 67,79 | +2,11% | 4,89% | 1.161.300 |
| 31/12/2025 | 66,51 | 67,26 | 66,00 | 66,39 | -1,28% | 1,89% | 1.066.300 |
| 30/12/2025 | 69,66 | 69,66 | 65,94 | 67,25 | -3,40% | 5,34% | 1.334.500 |
| 29/12/2025 | 69,39 | 69,69 | 68,00 | 69,62 | -0,77% | 2,44% | 896.700 |
| 26/12/2025 | 70,00 | 70,56 | 69,00 | 70,16 | +0,07% | 2,23% | 807.400 |
| 24/12/2025 | 68,47 | 71,30 | 68,00 | 70,11 | +0,40% | 4,82% | 678.000 |
| 23/12/2025 | 69,02 | 70,49 | 68,48 | 69,83 | +1,20% | 2,91% | 1.158.400 |
| 22/12/2025 | 68,07 | 69,47 | 67,60 | 69,00 | +1,23% | 2,75% | 1.017.600 |
| 19/12/2025 | 66,52 | 69,00 | 65,70 | 68,16 | +2,54% | 4,96% | 5.184.500 |
| 18/12/2025 | 65,60 | 67,30 | 64,22 | 66,47 | +2,58% | 4,70% | 1.994.300 |
| 17/12/2025 | 65,90 | 67,30 | 63,01 | 64,80 | +0,22% | 6,51% | 2.215.100 |
| 16/12/2025 | 68,05 | 68,15 | 59,51 | 64,66 | -5,54% | 12,70% | 3.775.900 |
| 15/12/2025 | 69,51 | 70,51 | 68,18 | 68,45 | -2,34% | 3,36% | 1.874.100 |
| 12/12/2025 | 70,82 | 71,00 | 68,01 | 70,09 | -1,03% | 4,22% | 1.555.200 |
| 11/12/2025 | 68,86 | 72,36 | 68,19 | 70,82 | +2,83% | 6,06% | 2.829.000 |
| 10/12/2025 | 68,09 | 70,50 | 65,93 | 68,87 | +0,06% | 6,71% | 4.294.300 |
| 09/12/2025 | 65,69 | 69,99 | 65,46 | 68,83 | +0,34% | 6,90% | 5.713.600 |
| 08/12/2025 | 67,09 | 71,50 | 65,40 | 68,60 | +11,65% | 9,09% | 5.070.900 |
| 05/12/2025 | 62,95 | 64,28 | 60,29 | 61,44 | -4,98% | 6,34% | 3.588.000 |
| 04/12/2025 | 64,40 | 67,14 | 64,19 | 64,66 | -0,64% | 4,58% | 3.060.200 |
| 03/12/2025 | 58,63 | 66,23 | 58,63 | 65,08 | +12,30% | 12,96% | 4.441.900 |
| 02/12/2025 | 55,91 | 59,27 | 55,75 | 57,95 | +3,02% | 6,30% | 2.867.400 |
| 01/12/2025 | 52,37 | 57,27 | 52,23 | 56,25 | +6,74% | 9,62% | 3.323.900 |
| 28/11/2025 | 56,39 | 56,67 | 52,08 | 52,70 | -8,68% | 8,14% | 2.540.700 |
| 26/11/2025 | 47,39 | 59,15 | 45,09 | 57,71 | +23,34% | 29,67% | 7.066.500 |
| 25/11/2025 | 44,26 | 46,92 | 43,72 | 46,79 | +5,72% | 7,23% | 2.951.000 |
| 24/11/2025 | 41,10 | 44,85 | 40,43 | 44,26 | +9,42% | 10,75% | 4.006.800 |
| 21/11/2025 | 38,01 | 40,58 | 37,43 | 40,45 | +6,20% | 8,29% | 3.506.500 |
| 20/11/2025 | 39,51 | 39,92 | 37,06 | 38,09 | -2,26% | 7,24% | 3.833.100 |
| 19/11/2025 | 41,06 | 41,29 | 38,90 | 38,97 | -3,71% | 5,82% | 2.882.000 |